The COVID-19 pandemic and resulting social restrictions have exposed individuals around the globe to additional stress, anxiety and an unprecedented and still-increasing number of mental health issues.
The changes in cognitive functioning and rising mental health challenges can be ascribed to limited social interaction, while our desire to combat these pitfalls is reflected in the increased interest in natural remedies, both for pharma and dietary purposes.
Linnea has provided ingredients from plants since 1982 and its product portfolio includes several extracts that can help manage depression, anxiety, sleep disorders, changes in appetite and health challenges.
Quality is our measure of excellence.
HUMANS
MENTAL HEALTH
Anxiety, depression, sleep disorders, psychosis, schizophrenia (positive symptoms), and addiction.
NEUROPROTECTION EFFECTS
In multiple sclerosis, Alzheimer’s Disease and Parkinson’s Disease, epilepsy (adults and children), and Huntington’s disease.
ANTIOXIDANT BENEFITS
PAIN AND INFLAMMATION MANAGEMENT
In psoriasis, rheumatoid arthritis, and infection.
PETS
Anxiety, nausea, pain, and inflammation
PLANT
Cannabis Sativa L.
PART OF THE PLANT USED
Aerial parts
APPEARANCE
Pale yellow
Linnea reference studies available upon request
REGULATES MOOD
Keeps emotions steady to prevent mild episodes.
REDUCES STRESS
Reduces stress-related symptoms, including PMS.
IMPROVES SLEEP QUALITY
Regulates circadian rhythms for more restful sleep.
SUPPORTS SPECIAL DIETS
Helps curb comfort eating.
PLANT
Griffonia simplicifolia
PART OF THE PLANT USED
Seeds
APPEARANCE
White to grey, white powder
CAS NUMBER
4350-08-9
Linnea reference studies available upon request
FIGHTS BRAIN AGING
IMPROVES CONCENTRATION AND MEMORY
Combats central nervous system disorders associated with chronic cerebral circulation insufficiency in the elderly.
COUNTERACTS CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY
Improves blood flow through cerebral (brain) vessels, thereby reducing hypoxia while increasing the brain’s glucose and oxygen uptake and utilization.
PLANT
Voacanga africana
PART OF THE PLANT USED
Seeds
APPEARANCE
White or slightly yellow crystalline powder
CAS NUMBER
42971-09-5
Linnea reference studies available upon request
IMPROVES MENTAL AND PHYSICAL PERFORMANCE
Combats disorders of vascular origin, such as hearing, visual, mental, mood, spatial, intellectual or ischemic disorders. Treats dizziness, vertigo, headaches of vascular origin and migraines.
FIGHTS AGING
Helps reduce memory disorders, including impaired concentration, attention and perception. Used to treat brain disorders in the elderly.
PLANT
Voacanga africana
PART OF THE PLANT USED
Seeds
APPEARANCE
White microcrystalline powder
CAS NUMBER
1617-90-9
Linnea reference studies available upon request
ENHANCES COGNITIVE FUNCTION
Ginkgo Biloba maintains capillary health, acts as an anti-oxidant, and improves memory loss and concentration disorders.
HELPS PERIPHERAL CIRCULATION
Our Ginkgo Biloba encourages blood circulation and safeguards the capillary health of the limbs (legs, hands, etc.)
REDUCES VERTIGO AND TINNITUS
Linnea Ginkgo improves microcirculation, and the local metabolism, by acting as an antioxidant and free-radical scavenger (membrane protection).
PLANT
Ginkgo biloba L.
PART OF THE PLANT USED
Leaves
APPEARANCE
Light brown, amorphous powder
CAS NUMBER
90045-36-6
Linnea reference studies available upon request
FIGHTS BRAIN AGING*
Helps fight neuroinflammation.
REDUCES OXIDATION AND CHRONIC INFLAMMATION*
Systemic protection from free radicals, chronic diseases and cell degeneration.
REDUCES TISSUE AGING*
Stimulates hyaluronic acid, collagen and elastin production.
MINIMIZES HOT FLASHES IN MENOPAUSE*
Reduces normal and severe events.
REDUCES CARDIOVASCULAR RISK FACTORS*
Improves vessel health and helps control blood sugar levels.
PLANT
Picea abies
PART OF THE PLANT USED
Wood knots
APPEARANCE
Off-white crystalline powder
Linnea reference studies available upon request
*HMRlignan™ has been registered as a New Dietary Ingredient (NDI) with the US FDA since 2004. The recommended daily ratio is – for any indication - 72 mg/day of HMRlignan™, as “Norway spruce knot extract, standardized as lignans in aglycone form (NLT 90%)”, corresponding to 50 mg of 7-hydroxymatairesinol.
Don’t hesitate to contact us for more information about our processes and products